Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: A systematic review and meta-analysis
Authors:
- 1 January 2020
- journal article
- review article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 159, 107974
Abstract
No abstract availableKeywords
Funding Information
- Royal Society of New Zealand
This publication has 54 references indexed in Scilit:
- Association between non-alcoholic fatty pancreatic disease (nafpd) and the metabolic syndrome: case–control retrospective studyCardiovascular Diabetology, 2013
- Latent associations of low serum amylase with decreased plasma insulin levels and insulin resistance in asymptomatic middle-aged adultsCardiovascular Diabetology, 2012
- Low serum amylase in association with metabolic syndrome and diabetes: A community-based studyCardiovascular Diabetology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- The islet-acinar axis of the pancreas: more than just insulinAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Obesity and Free Fatty AcidsEndocrinology and Metabolism Clinics of North America, 2008
- Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: Predominant localization in pancreatic polypeptide-secreting PP-cellsBiochemical and Biophysical Research Communications, 2006
- Mechanism of Exocrine Pancreatic Insufficiency in Streptozotocin‐Induced Type 1 Diabetes MellitusAnnals of the New York Academy of Sciences, 2006
- Exocrine pancreatic function in diabetes mellitus.Journal of Clinical Pathology, 1984
- Serum isoamylase activities in diabetes mellitus.Journal of Clinical Pathology, 1980